Immunoassay with cytomegalovirus early antigens from gene products p52 and CM2 (UL44 and UL57) detects active infection in patients with chronic fatigue syndrome.
Beqaj, S H, Lerner, A M, Fitzgerald, J T·Journal of clinical pathology·2008
This study tested a new blood test method to detect active cytomegalovirus (CMV) infection in ME/CFS patients. The new test, called Copalis, was more sensitive than standard tests at finding signs of active CMV infection, detecting it in about 12% of CMV-exposed patients compared to only 2% with the older method. The researchers suggest this improved test could help identify a subset of ME/CFS patients who have active CMV infection.